MOBIUS THERAPEUTICS, LLC
ST. LOUIS, MO

MOBIUS THERAPEUTICS, LLC, ST. LOUIS

Mobius Therapeutics, LLC Dedicated to helping ophthalmologists and their patients. With more than a century of combined experience in ophthalmology, the core management team of Mobius brings rock solid management and unmatched strategic vision to ophthalmic surgery. Each member of the sales team holds more than 20 years of direct clinical experience in the ophthalmic surgery field. Mobius Therapeutics aims to serve its customers, educate allied health, and contribute to the cause of high quality, affordable vision care. Mobius Therapeutics Mobius Therapeutics’ vision is to lead in ophthalmic perioperative pharmaceuticals. Our mission is to identify challenging needs and innovate solutions that continually improve patient care, patient access, and provider safety. We Are Here to Help! We Are Here to Help!

KEY FACTS ABOUT MOBIUS THERAPEUTICS, LLC

Company name
MOBIUS THERAPEUTICS, LLC
Status
Active
Filed Number
M11000000069
FEI Number
770686376
Date of Incorporation
January 5, 2011
Age - 14 years
Home State
DE
Company Type
Foreign Limited Liability

CONTACTS

Website
http://mobiustherapeutics.com
Phones
(877) 393-6486
(360) 904-5756
(510) 918-8875
(714) 328-5115
(801) 706-7439
(303) 910-0053
(214) 697-0137
(402) 681-7008
(314) 341-3744
(540) 520-2423
(504) 289-0481
(256) 626-9262
(612) 961-7510
(313) 718-6741
(513) 422-2281
(336) 681-8050
(770) 330-8528
(904) 610-0384
(772) 559-5272
(314) 605-4995
(314) 779-8132
(312) 213-7546

MOBIUS THERAPEUTICS, LLC NEAR ME

Principal Address
1000 EXECUTIVE PARKWAY,
ST. LOUIS,
MO,
63141,
US

See Also

Officers and Directors

The MOBIUS THERAPEUTICS, LLC managed by the two persons from ST. LOUIS on following positions: Chief Executive Officer, CFO

Edward J Timm

Position
Chief Executive Officer Active
From
ST. LOUIS, MO, 63141

Mark W Wright

Position
CFO Active
From
ST. LOUIS, MO, 63141





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2024
January 9, 2024
2023
January 11, 2023